FROM KNOWLEDGE TO SOLUTIONS
Where scientific rigor meets real-world healthcare impact
InnoValHC is an independent, not-for-profit research organization dedicated to the advancement of applied health economics, combining scientific excellence, senior expertise from academia and industry, and a trusted international network of experts. The projects are supported by its management unit, InnoValHC Research Inc., to help stakeholders successfully navigate the most demanding challenges in health economics, HTA, value assessment, pricing and reimbursement, R&D management, and patient access.
Contact us to find out how we can best support you to convert complexity into evidence, value, and access.
Challenging the Logic of Cost Effectiveness
At ISPOR Europe 2026, Michael Schlander offered an overview of emerging findings from an ongoing project to critically assess the use and limitations of CETs to inform decisions on health care coverage.
The Socioeconomic Impact of Cancer
At the European ISPOR 2026 Meeting, Michael Schlander outlined critical contents of a forthcoming White Paper on the Socioeconomic Impact of Cancer.
New Publication in the Discussion Paper Series
Tangible interim results include a completed systematic literature search, the IV Working Paper No. 39/2026, summarizing key insights from the first phase of the ongoing cost effectiveness threshold (CET) project.
Access to Rare and Complex Disease Therapies
Michael Schlander gave a presentation at the European Parliament in Brussels, Belgium, as part of the ´Health Leadership Mission for Rare Diseases´ (HLM4Rare) platform (July 01, 2026).
Advancing Health Economics with Scientific Integrity
We believe that health economics should serve as a bridge between medical innovation and sustainable, value-based, patient-centered healthcare systems. As an independent, highly specialized advisory team, we maintain strict scientific credibility while delivering high-impact solutions. We reject the rigid, one-size-fits-all models of traditional value analyses and instead provide objective, evidence-based insights that serve both private life science companies, public research organizations, and healthcare policy makers.
Our research service offers are designed to support our partners at every stage of the research, regulatory, and patient access challenges. Whether we are building advanced economic models for commercial therapies, delivering executive education, or participating in large European research consortia as a trusted health economics partner, our work is always anchored in scientific rigor and transparent methodology. Explore our core pillars to see how rigorous science meets our commitment to improving patient lives and shaping a fairer healthcare system.
Webinars, Workshops & Executive Seminars
Webinars, in-house training sessions, tailored workshops, and executive seminars in applied health economics, HTA, and patient access, designed for experts and professionals shaping healthcare decisions:
Learn. Webinars and online programs with internal and external experts.
Apply. In-house training sessions and tailored workshops to your real business challenges.
Decide. Executive seminars for better-informed choices and decisions in healthcare.
Explore the InnoValHC Academy´s course portfolio …